Advent France Biotechnology

Advent France Biotechnology

Advent France Biotechnology

Follow us
Alexa global traffic share
Latest investments
€21,000,000
Venture capital (Series A)
AgomAB
€21,000,000
Venture capital (Series A)
AgomAb Therapeutics
Team Size
1–10
Employees
Location
Headquarters
Past year's investments

Advent France Biotechnology participated in fewer than 3 rounds over the past year

Latest rounds
  • AgomAB: Venture capital (Series A) (€21M)
  • AgomAb Therapeutics: Venture capital (Series A) (€21M)
Main Co-investors